Concept: Adverse effect
Olutasidenib in recurrent/relapsed locally advanced or metastatic IDH1-mutated chondrosarcoma: phase 1b/2 trial
IDH1 inhibitor shows disease control in hard-to-treat cartilage tumors
Sustained regression of a tislelizumab-reactivated tuberculous focus after short-course therapy: a case report
Tuberculosis reactivation during cancer immunotherapy resolved with abbreviated drug therapy
Isoniazid-induced alopecia in isoniazid-monoresistant pulmonary tuberculosis
Hair loss in tuberculosis treatment may signal drug resistance
Adverse Childhood Experiences and Treatment-Resistant Depression
Early adversity linked to harder-to-treat depression in adulthood
Analysis of adverse event reporting with casimersen: a pharmacovigilance study based on the United States food and drug administration adverse event reporting system database
Safety patterns of casimersen revealed through real-world adverse event reports
Correlation between multi-parameter echocardiographic indicators and adverse pregnancy outcomes in women of advanced maternal age with pregnancy-induced hypertension syndrome: clinical application value
Heart imaging measures help predict complications in older pregnant women with high blood pressure
Durable three-year outcomes and persistent neuropathy following nine-month all-oral regimens for rifampicin-resistant tuberculosis: a multicentre cohort study in China
Long-term cure rates hold up after nine months of oral treatment, but nerve damage persists
Fecal microbiota transplantation plus immunotherapy in non-small cell lung cancer and melanoma: the phase 2 FMT-LUMINate trial
Gut bacteria transplants enhance immune cancer therapy effectiveness in lung and skin cancers
